CPhA recently sent out an alert notifying members of upcoming California State Board of Pharmacy adoption of USP <800> guidelines. You can read about it here. California isn’t planning to adopt the entirety of USP <800>, but what they have decided to adopt will become enforceable on January 1, 2017. “The proposed California BOP regulations … Read more
Show Notes: Host: Jerry Fahnri, Pharm.D. Short updates for the week ending March 26, 2016. I briefly touch on USP <800>, DrugCam semi-automated iv workflow management system, and the Grifols KIRO Robot Items discussed in podcast: USP <800> Article: DrugCam®—An intelligent video camera system to make safe cytotoxic drug preparations Cool i.v. room technology – … Read more
On March 14 I posted a piece called Recommendations for technology-assisted CSP preparation. The piece received a fair amount of traffic and some good feedback, including a comment left at my site – something that rarely happens. The comment’s author had some interesting, and valid, points. One item in particular caught my attention: I have … Read more
In this episode, Jerry talks Radio Frequency Identification (RFID) technology with Shariq Hussain, President and CEO and Jay Williams, VP of Business Development at MEPS Real-Time, Inc. MEPS Real-Time, Inc. is a market leader in RFID technologies in pharmacy. Jerry, Shariq, and Jay discuss RFID technologies, patient safety, and the companies two main products: Intelliguard … Read more
Both ISMP and ASHP are working on draft recommendations for technology in the IV room. ISMP’s version is an update to their ‘Guidelines for Safe Preparation of Sterile Compounds’ that was originally published in 2013. The proposed revision is open for public comment until April 10th. ASHP is also working on new recommendations for the … Read more
Clostridium difficile is a major problem in hospitals across the U.S. According to the CDC, it is estimated that C. difficile caused almost half a million infections in the U.S. in 2011, and approximately 83,000 of the patients who developed C. difficile experienced at least one recurrence and 29,000 died within 30 days of the … Read more
New York Times: “The federal Medicare program and private health insurers waste nearly $3 billion every year buying cancer medicines that are thrown out because many drug makers distribute the drugs only in vials that hold too much for most patients, a group of cancer researchers has found. …Â “Drug companies are quietly making billions … Read more